What is the difference in access to anti-retroviral drugs, male between Central African Republic and Guinea-Bissau?

1.0%, with Guinea-Bissau ahead.

How many years of comparable data are there for Central African Republic and Guinea-Bissau?

25 years are reported by both, from 2000 to 2024.

Where does this data come from?

UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Central African Republic vs Guinea-Bissau: Access to anti-retroviral drugs, male

Central African Republic

61.0%

in 2024

Guinea-Bissau

62.0%

in 2024

Central African Republic rank

97th

Guinea-Bissau rank

94th

Access to anti-retroviral drugs, male over time

Central African Republic
Guinea-Bissau

How they compare

Guinea-Bissau currently reports 62.0% against 61.0% in Central African Republic, a difference of 1.0%.

The two have swapped places 6 times across 25 shared years of data; in 2000 it was Guinea-Bissau ahead.

Central African Republic ranks 97th and Guinea-Bissau ranks 94th of 141 countries.

Central African Republic has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade	Central African Republic	Guinea-Bissau	Difference	Ahead
2000s	3.2%	2.0%	1.2%	Central African Republic
2010s	24.1%	19.4%	4.7%	Central African Republic
2020s	53.0%	48.0%	5.0%	Central African Republic

Averages of every year both report within each decade.

Frequently asked questions

Which has higher access to anti-retroviral drugs, male, Central African Republic or Guinea-Bissau?: Guinea-Bissau, at 62.0% against 61.0% in Central African Republic as of 2024.
What is the difference in access to anti-retroviral drugs, male between Central African Republic and Guinea-Bissau?: 1.0%, with Guinea-Bissau ahead.
How many years of comparable data are there for Central African Republic and Guinea-Bissau?: 25 years are reported by both, from 2000 to 2024.
How do Central African Republic and Guinea-Bissau rank globally for access to anti-retroviral drugs, male?: Central African Republic ranks 97th and Guinea-Bissau ranks 94th of 141 countries.
Where does this data come from?: UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Central African Republic vs Guinea-Bissau: Access to anti-retroviral drugs, male. Statizoid, drawing on UNAIDS estimates. Retrieved 17 September 2026, from https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-male-percent/central-african-republic/guinea-bissau/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-male-percent/central-african-republic/guinea-bissau/">Central African Republic vs Guinea-Bissau: Access to anti-retroviral drugs, male</a> — Statizoid

About this data

Indicator: Access to anti-retroviral drugs, male (%)
Unit: %
Source: UNAIDS estimates
Licence: CC BY 4.0 (World Bank Open Data)
Coverage: 160 places, 3,923 data points, 2000–2024
Last refreshed: 04 September 2026

The percentage of adult males living with HIV who are receiving antiretroviral therapy.